NEW YORK, May 22, 2017 /PRNewswire/ — Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Akari Therapeutics, Plc (“Akari” or the “Company”) (NASDAQ: AKTX) of the July 11, 2017 deadline to seek the role of lead plaintiff in a federal securities class…
May 23, 2017 at 03:19AM
from
No comments:
Post a Comment